RightFit Trial Directory

Obesity clinical trials in Houston, TX

37 recruiting obesity studies with a site in Houston, TX.

All trials in Houston, TX · All Obesity trials

RecruitingPhase 3NCT07654374

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Austin, TX · Farmers Branch, TX · Houston, TX · +71 more sites

RecruitingPhase 2NCT07752979

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Sponsor: AbbVie

Amarillo, TX · Austin, TX · Bellaire, TX · +56 more sites

RecruitingPhase 2NCT06273072

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Sponsor: Johns Hopkins University

Houston, TX · +1 more sites

RecruitingPhase 3NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Sponsor: Hoffmann-La Roche

Bellaire, TX · Brownsville, TX · Corpus Christi, TX · +41 more sites

RecruitingPhase 3NCT07595549

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Sponsor: Pfizer

Houston, TX · San Antonio, TX · +32 more sites

RecruitingPhase 3NCT07667803

A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DM

Sponsor: AstraZeneca

Dallas, TX · Houston, TX · Humble, TX · +53 more sites

RecruitingPhase 2NCT06897475

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Sponsor: Eli Lilly and Company

Houston, TX · Mesquite, TX · Round Rock, TX · +22 more sites

RecruitingPhase 3NCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Sponsor: Amgen

Amarillo, TX · Austin, TX · +137 more sites

RecruitingPhase 2NCT07589608

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Sponsor: Eli Lilly and Company

Austin, TX · Dallas, TX · Houston, TX · +37 more sites

RecruitingPhase 2NCT07783802

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

Sponsor: Eli Lilly and Company

Cypress, TX · Houston, TX · Kingwood, TX · +27 more sites

RecruitingPhase 3NCT07794579

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Sponsor: Eli Lilly and Company

Austin, TX · Brownsville, TX · Dallas, TX · +77 more sites

RecruitingNot applicableNCT04003038

Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction Surgery

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 2NCT06143956

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Sponsor: Eli Lilly and Company

Austin, TX · Dallas, TX · +47 more sites

RecruitingPhase 3NCT06672549

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Sponsor: Eli Lilly and Company

Austin, TX · Corpus Christi, TX · Houston, TX · +47 more sites

RecruitingPhase 3NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Sponsor: Amgen

Austin, TX · Bellaire, TX · Dallas, TX · +68 more sites

RecruitingPhase 3NCT07253285

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Sponsor: Novo Nordisk A/S

Houston, TX · San Antonio, TX · +31 more sites

RecruitingPhase 3NCT07533175

AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight

Sponsor: Novo Nordisk A/S

Dallas, TX · Houston, TX · +13 more sites

RecruitingPhase 3NCT07564414

A Research Study to Look at How Two Different Doses of CagriSema and One Dose of Semaglutide Help People Living With Obesity With or Without Type 2 Diabetes Lose Weight

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · +96 more sites

RecruitingPhase 3NCT07668414

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Sponsor: Novo Nordisk A/S

Amarillo, TX · Austin, TX · Brownsville, TX · +42 more sites

RecruitingEarly Phase 1NCT06759701

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 3NCT07776509

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Sponsor: AstraZeneca

Houston, TX · +22 more sites

RecruitingPhase 3NCT07784270

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Sponsor: AstraZeneca

DeSoto, TX · El Paso, TX · Houston, TX · +51 more sites

RecruitingPhase 2NCT06173778

Semaglutide for Post-Smoking Cessation Weight Management

Sponsor: The University of Texas Health Science Center, Houston

Austin, TX · Houston, TX

RecruitingPhase 3NCT07037459

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

Sponsor: Amgen

Amarillo, TX · Austin, TX · Conroe, TX · +118 more sites

RecruitingPhase 3NCT07743450

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Sponsor: Ascletis Pharma (China) Co., Limited

Austin, TX · Brownsville, TX · DeSoto, TX · +81 more sites

RecruitingPhase 4NCT06857942

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Sponsor: Eli Lilly and Company

Bellaire, TX · Dallas, TX · Houston, TX · +36 more sites

RecruitingPhase 3NCT06366464

A Study of Pitolisant in Patients With Prader-Willi Syndrome

Sponsor: Harmony Biosciences Management, Inc.

Houston, TX · San Antonio, TX · Weslaco, TX · +20 more sites

RecruitingPhase not listedNCT04611087

Self-monitoring Focus Groups With Vibrant Lives Pasadena Participants

Sponsor: M.D. Anderson Cancer Center

Houston, TX

RecruitingPhase 3NCT07654361

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics

Austin, TX · Denison, TX · +68 more sites

RecruitingNot applicableNCT06943001

Adapting and Assessing the Feasibility of a Telehealth Diabetes Prevention Program for Hispanic Adolescents

Sponsor: Baylor College of Medicine

Houston, TX

Not yet recruitingPhase 3NCT07881432

A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes

Sponsor: Eli Lilly and Company

Bellaire, TX · Dallas, TX · +52 more sites

Not yet recruitingPhase 3NCT07881458

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Sponsor: Eli Lilly and Company

Austin, TX · Fort Worth, TX · Houston, TX · +22 more sites

Not yet recruitingPhase 2NCT07874828

PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study

Sponsor: M.D. Anderson Cancer Center

Houston, TX

Not yet recruitingPhase 2NCT07820358

Semaglutide, Weight Loss, and LNG-IUD for Conservative Treatment of Endometrial Atypical Hyperplasia and Grade 1 Endometrial Cancer

Sponsor: The Methodist Hospital Research Institute

Houston, TX · +1 more sites

Not yet recruitingPhase 2NCT07349641

A Study of Weight Loss Intervention With Tirzepatide and Progestin Intrauterine Device to Treat Endometrial Hyperplasia and Grade 1 Endometrial Cancer

Sponsor: National Cancer Institute (NCI)

Houston, TX · +1 more sites

Not yet recruitingPhase 4NCT07554417

Combatting Muscle Loss in Obese Adult Patients on GLP-1 Medications Through Dietary Counseling and Exercise During Treatment Evaluates Whether a 12-week Exercise and Individualized Nutrition Program Can Reduce Muscle and Bone Loss and Improve Strength, Fitness, and Function in Obese Adults on GLP-1

Sponsor: William Marsh Rice University

Houston, TX

Not yet recruitingNot applicableNCT06668272

Small Changes Clinical Weight Loss Trial

Sponsor: The University of Texas Health Science Center, Houston

Houston, TX · Lubbock, TX

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.